High Court sets aside ban on new puberty-blocker prescriptions
The court found inadequate consultation and unjustified discrimination on the grounds of disability in the regulations banning new prescriptions for children and adolescents.
New Zealand’s High Court has set aside regulations banning new puberty-blocker prescriptions for children and adolescents with gender dysphoria or gender incongruence. In a judgment on 21 October, Justice La Hood found that consultation was inadequate, including a failure to consult affected young people directly.
The court also found unjustified discrimination on the ground of disability. This legal ground concerns recognised clinical diagnoses, rather than transgender identity itself.
The Professional Association for Transgender Health Aotearoa (PATHA) brought the challenge. PATHA president Jennifer Shields said the organisation was “incredibly relieved”. PATHA vice-president Dr Elizabeth McElrea welcomed the return of treatment decisions to patients and clinicians, describing the decision as putting them “back in the consult room”.
The minister defended the restrictions as a precautionary response to potential harm. While the judge accepted there was a rational basis for some restrictions, the court found an indefinite prohibition on new prescriptions was disproportionate.
The restrictions allowed existing prescriptions and treatment for other medical conditions to continue. Interim court orders had already prevented their enforcement while the case was heard.
The judgment leaves decisions about any future lawful restrictions to the minister and Cabinet. PATHA acknowledged a difficult year for trans young people and their families while they waited for the ruling.
Key facts
- The High Court set aside regulations banning new puberty-blocker prescriptions for children and adolescents with gender dysphoria or gender incongruence.
- Justice La Hood found the consultation was inadequate and that there was unjustified discrimination on the ground of disability.
- The judgment leaves decisions about any future lawful restrictions to the minister and Cabinet.
Three perspectives
Neutral
The High Court set aside regulations banning new puberty-blocker prescriptions for children and adolescents with gender dysphoria or gender incongruence, finding the consultation inadequate.
Positive
PATHA president Jennifer Shields said the organisation was “incredibly relieved” by the ruling.
Negative
The minister had defended the restrictions as a precautionary response to potential harm.
Your week in news, every Wednesday
The biggest stories of the week for your edition, in your inbox every Wednesday morning, your time. Free, and you can unsubscribe at any time.